P16 Positive SCCHN Recruiting Phase 2 Trials for Avelumab (DB11945)

IndicationStatusPhase
DBCOND0107095 (P16 Positive SCCHN)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03357757Avelumab With Valproic Acid in Virus-associated CancerTreatment